MedPath

Identification of biomarkers that predict responsiveness to Dupilumab among severe asthma

Not Applicable
Conditions
asthma
Registration Number
JPRN-UMIN000041915
Lead Sponsor
ational Hospital Organization Tokyo National Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Patient whom the researchers think is not suitable for the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath